X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1098) 1098
fibrinolysin - antagonists & inhibitors (1078) 1078
animals (593) 593
fibrinolysin - metabolism (427) 427
fibrinolysis (303) 303
male (266) 266
female (225) 225
kinetics (212) 212
index medicus (189) 189
plasminogen - metabolism (189) 189
biochemistry & molecular biology (184) 184
thrombin - antagonists & inhibitors (177) 177
plasmin (176) 176
fibrinolysis - drug effects (155) 155
hematology (154) 154
rats (144) 144
mice (143) 143
fibrinolysin - pharmacology (138) 138
cattle (129) 129
adult (117) 117
amino acid sequence (115) 115
urokinase-type plasminogen activator - antagonists & inhibitors (111) 111
cells, cultured (105) 105
in vitro techniques (103) 103
middle aged (102) 102
protease inhibitors (102) 102
structure-activity relationship (101) 101
molecular sequence data (99) 99
time factors (97) 97
peripheral vascular disease (96) 96
molecular weight (95) 95
urokinase-type plasminogen activator - metabolism (88) 88
kallikreins - antagonists & inhibitors (86) 86
plasminogen (86) 86
thrombin (86) 86
trypsin inhibitors (86) 86
plasminogen - antagonists & inhibitors (85) 85
binding sites (84) 84
fibrinolysin - analysis (81) 81
plasminogen activators - antagonists & inhibitors (80) 80
plasminogen activators - metabolism (80) 80
trypsin inhibitors - pharmacology (77) 77
protein binding (76) 76
serine proteinase inhibitors - pharmacology (76) 76
enzyme activation (73) 73
dose-response relationship, drug (72) 72
blood coagulation (71) 71
chymotrypsin - antagonists & inhibitors (70) 70
fibrin - metabolism (70) 70
expression (69) 69
rabbits (69) 69
blood coagulation - drug effects (68) 68
fibrin (68) 68
plasminogen - analysis (68) 68
plasminogen inactivators (66) 66
fibrinolysin - physiology (65) 65
aged (62) 62
aprotinin - pharmacology (62) 62
chromatography, gel (62) 62
electrophoresis, polyacrylamide gel (62) 62
activation (59) 59
fibrinogen - metabolism (59) 59
cell biology (58) 58
fibrinolytic agents - pharmacology (58) 58
antifibrinolytic agents - pharmacology (57) 57
urokinase (57) 57
chemistry, medicinal (55) 55
tissue plasminogen activator - metabolism (55) 55
binding (54) 54
pharmacology & pharmacy (54) 54
blood coagulation tests (53) 53
tissue plasminogen activator - antagonists & inhibitors (51) 51
antifibrinolytic agents (50) 50
chemical phenomena (50) 50
fibrinogen - analysis (50) 50
thrombin - metabolism (50) 50
chemistry (49) 49
swine (49) 49
streptokinase (48) 48
heparin - pharmacology (47) 47
research article (47) 47
pregnancy (46) 46
receptor (46) 46
cell line (45) 45
protease inhibitors - pharmacology (45) 45
system (45) 45
cells (44) 44
fibrinolysin - chemistry (44) 44
fibrinogen (43) 43
tumor cells, cultured (43) 43
aminocaproates - pharmacology (42) 42
plasminogen activators (42) 42
streptokinase - pharmacology (42) 42
tissue plasminogen activator - pharmacology (42) 42
hydrogen-ion concentration (41) 41
proteolysis (41) 41
enzyme inhibitors - pharmacology (40) 40
methods (40) 40
activator (39) 39
alpha-2-antiplasmin - metabolism (39) 39
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1328) 1328
German (84) 84
Russian (81) 81
Japanese (77) 77
French (23) 23
Polish (10) 10
Italian (5) 5
Portuguese (2) 2
Spanish (2) 2
Dutch (1) 1
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Pharmacology, ISSN 0007-1188, 12/2013, Volume 170, Issue 7, pp. 1421 - 1435
Background and Purpose The conversion of plasminogen into plasmin by interstitial urokinase plasminogen activator (uPA) is potentially important in asthma... 
asthma | α2‐antiplasmin | airway wall remodelling | annexin A2 hetero‐tetramer | EGF | plasmin | annexin A2 hetero-tetramer | α2-antiplasmin | LUNG | COLLAGEN | BRONCHIAL EPITHELIAL-CELLS | RECEPTOR | MODEL | CANCER | 2-antiplasmin | PATHWAY | INFLAMMATION | PHARMACOLOGY & PHARMACY | TUMOR-GROWTH | Cyclin D1 - metabolism | Receptor, Epidermal Growth Factor - genetics | Urokinase-Type Plasminogen Activator - antagonists & inhibitors | Bronchi - enzymology | Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Humans | Hyperplasia | Myocytes, Smooth Muscle - pathology | Extracellular Signal-Regulated MAP Kinases - antagonists & inhibitors | Plasminogen - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Bronchi - drug effects | Muscle, Smooth - drug effects | Receptor, Epidermal Growth Factor - metabolism | Transfection | RNA Interference | Time Factors | Myocytes, Smooth Muscle - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Bronchi - pathology | Fibrinolysin - metabolism | Phosphatidylinositol 3-Kinase - metabolism | Serine Proteinase Inhibitors - pharmacology | Myocytes, Smooth Muscle - enzymology | Cells, Cultured | Urokinase-Type Plasminogen Activator - genetics | Annexin A2 - genetics | Signal Transduction - drug effects | Urokinase-Type Plasminogen Activator - metabolism | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Annexin A2 - metabolism | Muscle, Smooth - pathology | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Muscle, Smooth - enzymology | Smooth muscle | Epidermal growth factor | Thrombolytic drugs | Annexins | Asthma | Research Papers
Journal Article
Current Alzheimer Research, ISSN 1567-2050, 04/2008, Volume 5, Issue 2, pp. 212 - 224
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e53343
Kunitz-type serine protease inhibitors are involved in various physiological processes, such as ion channel blocking, blood coagulation, fibrinolysis, and... 
VENOM | KING COBRA | MULTIDISCIPLINARY SCIENCES | PSEUDONAJA-TEXTILIS | SILK PROTEIN | CHYMOTRYPSIN INHIBITOR | MOLECULAR-CLONING | BOOPHILUS-MICROPLUS | EXPRESSION | ARANEUS-VENTRICOSUS | PEPTIDE | Factor Xa - chemistry | Chymotrypsin - metabolism | Molecular Sequence Data | Baculoviridae - genetics | Tissue Plasminogen Activator - chemistry | Pancreatic Elastase - antagonists & inhibitors | Antifibrinolytic Agents - metabolism | Trypsin Inhibitors - chemistry | Serine Proteinase Inhibitors - chemistry | Spiders - metabolism | Aprotinin - genetics | Conserved Sequence | Antifibrinolytic Agents - chemistry | Spiders - chemistry | Protein Structure, Tertiary | Amino Acid Sequence | Gene Expression | Fibrinolysin - antagonists & inhibitors | Recombinant Proteins - chemistry | Arthropod Proteins - genetics | Recombinant Proteins - genetics | Trypsin - metabolism | Arthropod Proteins - chemistry | Fibrinolysin - chemistry | Sequence Alignment | Animals | Thrombin - chemistry | Trypsin Inhibitors - genetics | Chymotrypsin - antagonists & inhibitors | Pancreatic Elastase - chemistry | Aprotinin - chemistry | Serine Proteinase Inhibitors - genetics | Enzymes | Care and treatment | Protease inhibitors | Physiological aspects | Hydrolases | Inflammation | Research | Health aspects | Risk factors | Blood coagulation | Serine | Thrombin | Amino acids | Baculovirus | Plasmin | t-Plasminogen activator | Proteins | Protease | Ion channels | Elastase | Inhibition | Recombinant | Natural resources | Proteinase inhibitors | Potassium channels | Fibrinolysis | Chymotrypsin | Trypsin | Insects | Proteases | Lysine | Venom | Insect cells | Serine proteinase
Journal Article
Biochemistry, ISSN 0006-2960, 04/2003, Volume 42, Issue 13, pp. 3874 - 3881
Journal Article
Critical Care Medicine, ISSN 0090-3493, 06/2016, Volume 44, Issue 6, pp. e390 - e402
OBJECTIVE:Platelet-derived growth factor-BB activates platelet-derived growth factor receptor-β and promotes vascular smooth muscle cell phenotypic... 
intracerebral hemorrhage | vascular smooth muscle cell | neuroinflammation | platelet-derived growth factor receptor β | platelet-derived growth factor-BB | phenotypic transformation | SIGNALING PATHWAYS | platelet-derived growth factor receptor beta | BLOOD-BRAIN-BARRIER | RAT MODEL | ADHESION MOLECULE-1 | INFLAMMATION | DISEASE | PLASMIN | CENTRAL-NERVOUS-SYSTEM | NF-KAPPA-B | EXPRESSION | CRITICAL CARE MEDICINE | Cerebral Hemorrhage - metabolism | Nonmuscle Myosin Type IIB - metabolism | Muscle, Smooth, Vascular - metabolism | Actins - metabolism | Male | Intracellular Signaling Peptides and Proteins - metabolism | Receptor, Platelet-Derived Growth Factor beta - genetics | Protein-Serine-Threonine Kinases - antagonists & inhibitors | p38 Mitogen-Activated Protein Kinases - metabolism | Proto-Oncogene Proteins c-sis - pharmacology | Protein-Serine-Threonine Kinases - metabolism | Receptor, Platelet-Derived Growth Factor beta - metabolism | Brain Edema - etiology | Proto-Oncogene Proteins c-sis - metabolism | Signal Transduction | Imatinib Mesylate - pharmacology | Nonmuscle Myosin Type IIB - genetics | Fibrinolysin - antagonists & inhibitors | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | RNA, Small Interfering - pharmacology | Neutrophils - physiology | Muscle, Smooth, Vascular - cytology | Fibrinolytic Agents - pharmacology | Intercellular Adhesion Molecule-1 - metabolism | Phenotype | Animals | Brain Edema - drug therapy | Mice | Fibrinolysin - pharmacology | Cerebral Hemorrhage - complications
Journal Article
The Journal of Immunology, ISSN 0022-1767, 08/2003, Volume 171, Issue 4, pp. 2057 - 2065
Journal Article
Journal Article
Journal of Periodontal Research, ISSN 0022-3484, 12/2009, Volume 44, Issue 6, pp. 726 - 735
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e54104
Journal Article
Journal Article